Literature DB >> 8021589

A recombinant viral haemorrhagic septicaemia virus glycoprotein expressed in insect cells induces protective immunity in rainbow trout.

F Lecocq-Xhonneux1, M Thiry, I Dheur, M Rossius, N Vanderheijden, J Martial, P de Kinkelin.   

Abstract

Viral haemorrhagic septicaemia (VHS) is a fish rhabdovirus infection of world-wide importance. Control policies have been established but the disease still causes heavy losses in fish farming. The development of a recombinant subunit vaccine was initiated to produce a safe and effective vaccine to protect fish against VHS. The VHS virus (VHSV) glycoprotein, which induces neutralizing antibodies in rainbow trout, was chosen for expression in insect cells using a baculovirus vector. The M(r) of the recombinant protein estimated by SDS-PAGE was slightly lower than that of the native viral protein. The recombinant protein displayed different degrees of glycosylation and was recognized in ELISA by neutralizing antibodies. It was transported to the plasma membrane of insect cells where its ability to induce membrane fusion was preserved. The efficacy of the recombinant protein as a vaccine was compared with those of an inactivated and an attenuated vaccine. When injected intraperitoneally into rainbow trout, the baculovirus-encoded protein was shown (i) to induce the synthesis of VHSV-neutralizing antibodies and (ii) to confer protection against virus challenge. Immunization performed by immersion failed. This is the first report of a recombinant vaccine that protects fish against VHSV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021589     DOI: 10.1099/0022-1317-75-7-1579

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  The glycoprotein G of rhabdoviruses.

Authors:  J M Coll
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Fundamentals of Fish Vaccination.

Authors:  Megha Kadam Bedekar; Sajal Kole
Journal:  Methods Mol Biol       Date:  2022

3.  Antibody recognition of the glycoprotein g of viral haemorrhagic septicemia virus (VHSV) purified in large amounts from insect larvae.

Authors:  Paloma Encinas; Silvia Gomez-Sebastian; Maria Carmen Nunez; Eduardo Gomez-Casado; Jose M Escribano; Amparo Estepa; Julio Coll
Journal:  BMC Res Notes       Date:  2011-06-21

Review 4.  A Review of Intra- and Extracellular Antigen Delivery Systems for Virus Vaccines of Finfish.

Authors:  Hetron Mweemba Munang'andu; Øystein Evensen
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

Review 5.  Turbot (Scophthalmus maximus) vs. VHSV (Viral Hemorrhagic Septicemia Virus): A Review.

Authors:  Patricia Pereiro; Antonio Figueras; Beatriz Novoa
Journal:  Front Physiol       Date:  2016-05-26       Impact factor: 4.566

6.  The glycoprotein, non-virion protein, and polymerase of viral hemorrhagic septicemia virus are not determinants of host-specific virulence in rainbow trout.

Authors:  Shamila Yusuff; Gael Kurath; Min Sun Kim; Tarin M Tesfaye; Jie Li; Douglas G McKenney; Vikram N Vakharia
Journal:  Virol J       Date:  2019-03-07       Impact factor: 4.099

Review 7.  Entry of rhabdoviruses into animal cells.

Authors:  Andrew D Regan; Gary R Whittaker
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Heptad-repeat sequences in the glycoprotein of rhabdoviruses.

Authors:  J M Coll
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

Review 9.  A Review of Fish Vaccine Development Strategies: Conventional Methods and Modern Biotechnological Approaches.

Authors:  Jie Ma; Timothy J Bruce; Evan M Jones; Kenneth D Cain
Journal:  Microorganisms       Date:  2019-11-16

10.  Transcriptome profiles associated to VHSV infection or DNA vaccination in turbot (Scophthalmus maximus).

Authors:  Patricia Pereiro; Sonia Dios; Sebastián Boltaña; Julio Coll; Amparo Estepa; Simon Mackenzie; Beatriz Novoa; Antonio Figueras
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.